Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite a hectic schedule this week filled with meetings and a speaking engagement. This explains the sporadic posting, other than the usual morning missives. Nonetheless, we are motoring along, thanks to a few cups of stimulation. So time to get on with it. Here are a few items of interest to help you cope with your own busy schedule. Hope you conquer the world today and do keep us in mind when something interesting pops. …

Merck (MRK) has begun to prepare for the departure of chief executive officer Ken Frazier and is focusing its search for an eventual successor on a pool of internal candidates, Bloomberg News writes. Last September, Merck disclosed that Frazier would remain beyond 2019, rolling back a policy that would have required him to retire when he turns 65 in December. But now, Merck is laying the groundwork for his exit, as well as that of its seasoned research and development leader Roger Perlmutter, who is 66.


Amazon (AMZN) is seeking to contract directly with health plans and employers to sell prescription drugs through its PillPack subsidiary, a move that would cut out existing pharmacy benefit managers and potentially reshape the sale and distribution of medicines in the U.S., STAT writes. The revelations are contained in a lawsuit CVS (CVS) filed in April seeking to prevent one of its former executives from taking a job at PillPack, an online pharmacy based in New Hampshire.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!